nach oben

Erschienen in:

26.10.2019 | Bewegungstherapie | Supportivtherapie

Neue ACSM-Leitlinienempfehlungen

Körperliche Aktivität vor, während und nach Krebserkrankung

verfasst von: PD Dr. Joachim Wiskemann, Annelie Voland, Maximilian Köppel

Erschienen in: Im Fokus Onkologie | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Inaktivität vermeiden, mindestens 150 Minuten moderate körperliche Aktivität pro Woche, dazu zweimal wöchentlich kräftigende Übungen für die Hauptmuskulatur sowie tägliche Dehnübungen, so lauteten die Empfehlungen für Krebspatienten des American College of Sports Medicine (ACSM) aus dem Jahr 2010. Nun, etwa 10 Jahre später, am 16. Oktober 2019 wurden die neuen internationalen Leitlinienempfehlungen zu Sport und Bewegung in Prävention und Therapie von Krebserkrankungen durch das ACSM veröffentlicht.

Sweegers MG et al. Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. BJSM online. 2018;52(8):505–13CrossRef

Scott JM et al. Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis. J Clin Oncol. 2018;36(22):2297–305PubMedCrossRefPubMedCentral

Jones LW et al. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016;34(23):2743–9PubMedPubMedCentralCrossRef

Scott JM et al. Exercise Therapy and Cardiovascular Toxicity in Cancer. Circulation. 2018;137(11):1176–91PubMedPubMedCentralCrossRef

Duregon F et al. Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review. Crit Rev Oncol Hematol. 2018;121:90–100PubMedCrossRef

Zimmer P et al. Effects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic Review. Biomed Res Int. 2016;2016:1820954PubMedPubMedCentralCrossRef

Campbell KL et al. Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med. 2012;46(13):909–16.PubMedCrossRef

Winters-Stone KM et al. Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv. 2014;8(2):260–8PubMedPubMedCentralCrossRef

Cormie P et al. The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev. 2017;39(1):71–92PubMedCrossRef

10.

Ashcraft KA et al. Exercise as Adjunct Therapy in Cancer. Semin Radiat Oncol. 2019;29(1):16–24PubMedCrossRefPubMedCentral

11.

Behrens G et al. The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis. Eur J Epidemiol. 2014;29(3):151–70PubMedCrossRef

12.

Behrens G, Leitzmann MF. The association between physical activity and renal cancer: systematic review and meta-analysis. Br J Cancer. 2013;108(4):798–811PubMedPubMedCentralCrossRef

13.

Keimling M et al. The association between physical activity and bladder cancer: systematic review and meta-analysis. Br J Cancer. 2014;110(7):1862–70PubMedPubMedCentralCrossRef

14.

Schmid D et al. A systematic review and meta-analysis of physical activity and endometrial cancer risk. Eur J Epidemiol. 2015;30(5):397–412PubMedCrossRef

15.

Wolin KY et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009;100(4):611–6PubMedPubMedCentralCrossRef

16.

Brenner DR et al. Leisure-time physical activity and lung cancer risk: A systematic review and meta-analysis. Lung Cancer. 2016;95:17–27PubMedCrossRef

17.

Behrens G et al. Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2015;30(4):279–98PubMedCrossRef

18.

Jochem C et al. Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis. Cancer Cancer Epidemiol Biomarkers Prev. 2014;23(5):833–46PubMedCrossRef

19.

Niedermaier T et al. Body mass index, physical activity, and risk of adult meningioma and glioma: a meta-analysis. Neurology. 2015;85(15):1342–50PubMedCrossRef

20.

Schmid D et al. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2013;28(12):945–58PubMedCrossRef

21.

Leitzmann MF et al. Physical activity and head and neck cancer risk. Cancer Causes Control. 2008;19(10):1391–9PubMedPubMedCentralCrossRef

22.

Liu Y et al. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol. 2011;60(5):1029–44PubMedCrossRef

23.

Zhong S et al. Nonoccupational physical activity and risk of ovarian cancer: a meta-analysis. Tumour Biol. 2014;35(11):11065–73PubMedCrossRef

24.

Moore SC et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176(6):816–25PubMedPubMedCentralCrossRef

25.

Freedman ND et al. Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIHAARP cohort. Int J Epidemiol. 2015;45(3):846–56PubMedPubMedCentralCrossRef

26.

Lai JK et al. Prospective observational study of physical functioning, physical activity, and time outdoors and the risk of hip fracture: A population-based cohort study of 158,057 older adults in the 45 and up study. J Bone Miner Res. 2013;28(10):2222–31PubMedCrossRef

27.

WHO. World Health Organization. Global recommandations on physical activity for health. 2010; https://www.who.int/dietphysicalactivity/publications/9789241599979/en/

28.

Pfeifer K, Rutten A. Nationale Empfehlungen für Bewegung und Bewegungsförderung. Gesundheitswesen. 2017;79(S 01):S2–S3PubMed

29.

Courneya KS et al. Effects of supervised exercise on progression-free survival in lymphoma patients: an exploratory follow-up of the HELP Trial. Cancer Causes Control. 2015;26(2):269–76PubMedCrossRef

30.

Courneya KS et al. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc. 2014;46(9):1744–51PubMedCrossRef

31.

Hayes SC et al. Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials. Breast Cancer Res Treat. 2018;167(2):505–14PubMedCrossRef

32.

Wiskemann J et al. Effects of physical exercise on survival after allogeneic stem cell transplantation. Int J Cancer. 2015;137(11):2749–56PubMedCrossRef

33.

Rief H et al. Resistance training concomitant to radiotherapy of spinal bone metastases—survival and prognostic factors of a randomized trial. Radiat Oncol. 2016;11(1):97PubMedPubMedCentralCrossRef

34.

Courneya KS et al. The colon health and lifelong exercise change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008;15(6):271PubMedCentralCrossRef

35.

Courneya KS et al. The Alberta moving beyond breast cancer (AMBER) cohort study: recruitment, baseline assessment, and description of the first 500 participants. BMC Cancer. 2016;16(1):481PubMedPubMedCentralCrossRef

36.

Newton RU et al. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open. 2018;8(5):e022899PubMedPubMedCentralCrossRef

37.

Hayes SC et al. Exercise during chemotherapy for ovarian cancer (Echo): study design features and outcomes of a Cancer Australia and Cancer Council Australia funded randomised, controlled trial. Int J Gynecol Cancer. 2014;24(9 Suppl 4):Abstr IGCSM–0677

38.

Wiskemann J et al. Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study)—Rationale and design of a randomized trial to evaluate a year-long exercise intervention on overall survival and side-effects after allogeneic stem cell transplantation. BMC Cancer. 2015;15(1):619PubMedPubMedCentralCrossRef

39.

Schmid D, Leitzmann MF. Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis. J Natl Cancer Inst. 2014;106(7):dju098PubMedCrossRef

40.

Shen D et al. Sedentary behavior and incident cancer: a meta-analysis of prospective studies. PLoS One. 2014;9(8):e105709PubMedPubMedCentralCrossRef

41.

Biswas A et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015;162(2):123–32PubMedCrossRef

42.

Koelwyn GJ et al. Exercise-dependent regulation of the tumour microenvironment. Nat Rev Cancer. 2017;17(10):620CrossRefPubMed

43.

Neilson HK et al. The influence of energetic factors on biomarkers of postmenopausal breast cancer risk. Curr Nutr Rep. 2014;3(1):22–34PubMedCrossRef

44.

Hojman P et al. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell metabolism. 2018;27(1):10–21PubMedCrossRef

45.

Giovannucci E et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60(4):207–21PubMedCrossRef

46.

Simpson RJ et al. Exercise and the regulation of immune functions. Prog Mol Biol Transl Sci. 2015;135:355–80PubMedCrossRef

47.

Campbell KL et al. Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1767–74PubMedCrossRef

48.

McTiernan et al. Effect of a 12-month exercise intervention on patterns of cellular proliferation in colonic crypts: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1588–97PubMedCrossRef

49.

Figueira ACC et al. Efficacy of exercise on breast cancer outcomes: A systematic review and meta-analysis of preclinical data. Int J Sports Med. 2018;39(05):327–42PubMedCrossRef

50.

Ashcraft KA et al. Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data. Cancer Res. 2016;76(14):4032–50PubMedPubMedCentralCrossRef

51.

Scharhag-Rosenberger F et al. Recommendations for Assessment Methods for Exercise Trials with Cancer Patients. Dtsch Z Sportmed. 2014;65(11):304–13CrossRef

52.

Wiskemann J, Scharhag-Rosenberger F. Nebenwirkungsorientierte Behandlungspfade für die bewegungstherapeutische Betreuung onkologischer Patienten. Bewegungstherapie und Gesundheitssport. 2014;30(4):146–50CrossRef

53.

Patel AV et al. American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Med Sci Sports Exerc. 2019; https://doi.org/10.1249/MSS.0000000000002117CrossRef

54.

Campbell KL et al. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019; https://doi.org/10.1249/MSS.0000000000002116; CrossRef

55.

Schmitz KH et al. Exercise Is Medicine in Oncology: Engaging Clinicians to Help Patients Move Through Cancer. CA Cancer J Clin. 2019; https://doi.org/10.3322/caac.21579

Titel: Neue ACSM-Leitlinienempfehlungen
Körperliche Aktivität vor, während und nach Krebserkrankung
verfasst von: PD Dr. Joachim Wiskemann
Annelie Voland
Maximilian Köppel
Publikationsdatum: 26.10.2019
Verlag: Springer Medizin
Schlagwörter: Bewegungstherapie
Bewegungstherapie
Erschienen in: Im Fokus Onkologie / Ausgabe 5/2019
Print ISSN: 1435-7402
Elektronische ISSN: 2192-5674
DOI: https://doi.org/10.1007/s15015-019-0226-z

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Körperliche Aktivität vor, während und nach Krebserkrankung

Zusammenfassung

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

microRNA ist zuverlässiger als gängige Tumormarker

Allogene HSZT: Fokus auf die Kinder

Krebsrisiko bei chronischer Hepatitis B senken

Prostatakarzinom: Nur wiederholtes PSA-Screening senkt die Mortalität

Brustbestrahlung bei Mammakarzinom: hypofraktioniert oder konventionell?

Ist die einmal tägliche Bestrahlung beim Kleinzeller besser?

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie